Logo image of SHLT

SHL TELEMEDICINE LTD-ADR (SHLT) Stock Fundamental Analysis

NASDAQ:SHLT - Nasdaq - US78423T2006 - ADR - Currency: USD

2.05  -0.03 (-1.44%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SHLT. SHLT was compared to 105 industry peers in the Health Care Providers & Services industry. SHLT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SHLT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SHLT had negative earnings in the past year.
In the past year SHLT had a positive cash flow from operations.
In multiple years SHLT reported negative net income over the last 5 years.
In multiple years SHLT reported negative operating cash flow during the last 5 years.
SHLT Yearly Net Income VS EBIT VS OCF VS FCFSHLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M -15M

1.2 Ratios

SHLT has a Return On Assets of -8.60%. This is in the lower half of the industry: SHLT underperforms 71.96% of its industry peers.
SHLT has a worse Return On Equity (-13.13%) than 62.62% of its industry peers.
Industry RankSector Rank
ROA -8.6%
ROE -13.13%
ROIC N/A
ROA(3y)-5.73%
ROA(5y)-1.45%
ROE(3y)-11.52%
ROE(5y)-3.49%
ROIC(3y)N/A
ROIC(5y)N/A
SHLT Yearly ROA, ROE, ROICSHLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

SHLT has a Gross Margin of 45.73%. This is in the better half of the industry: SHLT outperforms 73.83% of its industry peers.
In the last couple of years the Gross Margin of SHLT has declined.
SHLT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-6.47%
SHLT Yearly Profit, Operating, Gross MarginsSHLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

4

2. Health

2.1 Basic Checks

SHLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SHLT has been increased compared to 1 year ago.
SHLT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SHLT has been reduced compared to a year ago.
SHLT Yearly Shares OutstandingSHLT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
SHLT Yearly Total Debt VS Total AssetsSHLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

SHLT has an Altman-Z score of -0.08. This is a bad value and indicates that SHLT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.08, SHLT is doing worse than 76.64% of the companies in the same industry.
SHLT has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
SHLT's Debt to Equity ratio of 0.20 is fine compared to the rest of the industry. SHLT outperforms 69.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z -0.08
ROIC/WACCN/A
WACC7.08%
SHLT Yearly LT Debt VS Equity VS FCFSHLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.17 indicates that SHLT has no problem at all paying its short term obligations.
The Current ratio of SHLT (2.17) is better than 76.64% of its industry peers.
A Quick Ratio of 1.98 indicates that SHLT should not have too much problems paying its short term obligations.
SHLT has a better Quick ratio (1.98) than 74.77% of its industry peers.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 1.98
SHLT Yearly Current Assets VS Current LiabilitesSHLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

1

3. Growth

3.1 Past

SHLT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -282.35%.
Looking at the last year, SHLT shows a decrease in Revenue. The Revenue has decreased by -2.04% in the last year.
The Revenue has been growing slightly by 3.16% on average over the past years.
EPS 1Y (TTM)-282.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.41%
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y12.43%
Revenue growth 5Y3.16%
Sales Q2Q%-3.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SHLT Yearly Revenue VS EstimatesSHLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
SHLT Yearly EPS VS EstimatesSHLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 0.2 0.4 0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SHLT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SHLT Price Earnings VS Forward Price EarningsSHLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SHLT Per share dataSHLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SHLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SHL TELEMEDICINE LTD-ADR

NASDAQ:SHLT (4/2/2025, 8:00:02 PM)

2.05

-0.03 (-1.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)04-24 2025-04-24
Inst Owners27.15%
Inst Owner Change0%
Ins Owners5.8%
Ins Owner ChangeN/A
Market Cap33.60M
Analysts40
Price TargetN/A
Short Float %0.12%
Short Ratio1.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF 23.16
P/B 0.5
P/tB 2.07
EV/EBITDA N/A
EPS(TTM)-0.54
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)0.09
OCFY4.32%
SpS3.41
BVpS4.11
TBVpS0.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.6%
ROE -13.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.73%
FCFM N/A
ROA(3y)-5.73%
ROA(5y)-1.45%
ROE(3y)-11.52%
ROE(5y)-3.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-6.47%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.04%
Cap/Sales 9.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 1.98
Altman-Z -0.08
F-Score5
WACC7.08%
ROIC/WACCN/A
Cap/Depr(3y)76.24%
Cap/Depr(5y)63.01%
Cap/Sales(3y)9.3%
Cap/Sales(5y)7.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-282.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y12.43%
Revenue growth 5Y3.16%
Sales Q2Q%-3.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-33.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.12%
OCF growth 3YN/A
OCF growth 5YN/A